Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort descending
2007 R43 RFA-CA-07-008 GORDON, NEAL FRANCIS EPITOME BIOSYSTEMS, INC A STANDARDIZED ANTIBODY MICROARRAY-BASED SYSTEM FOR THE QUANTITATIVE MEASUREMENT Complete
2010 R33 RFA-CA-09-007 KENIS, PAUL J. A. UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN FRET-BASED BIOSENSORS TO MONITOR REDOX IN CELL CYCLE REGULATION Complete
2014 R33 RFA-CA-13-004 TURESKY, ROBERT J. UNIVERSITY OF MINNESOTA CARCINOGEN DNA ADDUCT BIOMARKERS IN FORMALIN FIXED TISSUES Complete
2017 R33 RFA-CA-16-002 MAKRIGIORGOS, G. MIKE DANA-FARBER CANCER INST Maximum efficiency sequencing using nuclease-based mutation enrichment and digital barcodes Complete
2001 R33 PAR-98-067 WIND, ROBERT A BATTELLE PACIFIC NORTHWEST LABORATORIES INTEGRATED OPTICAL/MAGNETIC RESONANCE MICROSCOPY Complete
2003 R43 PAR-01-105 DIATCHENKO, LUDA ATTAGENE, INC. PROFILING OF SIGNAL TRANSDUCTION PATHWAYS IN CANCER Complete
2007 R21 RFA-CA-07-002 COOPER, LAURENCE J.N. UT MD ANDERSON CANCER CTR UCB-DERIVED CD19-SPECIFIC T CELLS FOR UNIVERSAL TREATMENT OF B-CELL MALIGNANCY Complete
2009 R44 RFA-CA-08-013 ZOU, NIANXIANG BIO-QUICK CORPORATION DEVELOPMENT OF ULTRASOUND-FACILITATED FORMALIN-FIXED AND PARAFFIN-EMBEDDED TISSUE Complete
2013 R33 RFA-CA-12-005 SCHLEGEL, RICHARD GEORGETOWN UNIVERSITY CONDITIONALLY REPROGRAMMED CELLS AS A NOVEL TOOL FOR BIOBANKING Complete
2016 R33 RFA-CA-15-003 LIN, QIAO COLUMBIA UNIV NEW YORK MORNINGSIDE Validating Rapid Microfluidic Isolation of Personalized Aptamers for Monitoring Minimal Residual Disease in Multiple Myeloma Complete
2020 R44 PAR-18-303 LIM, MARK AMBERGEN, INC Highly Multiplexed Nanoscale Mass Spectrometric Imaging Of Cancer Tissues Complete
2017 R21 RFA-CA-16-001 WALTER, NILS G UNIVERSITY OF MICHIGAN AT ANN ARBOR Single-molecule counting of cancer biomarker miRNAs in human biofluids Complete
2020 R43 PAR-18-303 REDER, NICHOLAS LIGHTSPEED MICROSCOPY, INC. Open-top Light-sheet Microscopy For Non-destructive 3d Pathology Of Prostate Biopsies Complete
2000 R43 PAR-99-101 GOLOVLEV, VAL V SCI-TEC, INC. MAGNETIC DISK ARRAY DNA ANALYZER Complete
2002 R43 PAR-01-105 HANCOCK, LAWRENCE F NOMADICS, INC. POLYMER AMPLIFIED NUCLEIC ACID DETECTION Complete
2006 R21 RFA-CA-06-004 JU, JINGFANG UNIVERSITY OF SOUTH ALABAMA NOVEL METHOD FOR ISOLATING ACTIVELY TRANSLATED MRNAS Complete
2009 R21 RFA-CA-08-006 KANDEL, EUGENE S ROSWELL PARK CANCER INSTITUTE CORP ARRAY-ASSISTED INSERTIONAL MUTAGENESIS FOR MOLECULAR ANALYSIS OF CANCER Complete
2013 R21 RFA-CA-12-002 LU, CHANG VIRGINIA POLYTECHNIC INST AND ST UNIV SENSITIVE AND INTEGRATED MICROFLUIDIC CHIP ASSAYS FOR STUDYING TRANSCRIPTIONAL RE Complete
2016 R21 RFA-CA-15-002 RECHT, MICHAEL PALO ALTO RESEARCH CENTER HIGH-THROUGHPUT SCREENING PLATFORM FOR CANCER DRUG DISCOVERY Complete
2019 R33 RFA-CA-18-003 YANG, JENNY J. GEORGIA STATE UNIVERSITY Multi-color Mapping of Cancer Molecular Signatures and Tumor microenvironment Complete
2000 R21 PAR-99-100 MALKHOSYAN, SERGEI R BURNHAM INSTITUTE FOR MEDICAL RESEARCH COMPARATIVE HYBRIDIZATION OF AP PCR ARRAYS Complete
2002 R33 PAR-01-104 SPEICHER, DAVID W. WISTAR INSTITUTE DEVELOPMENT OF METHODS FOR CANCER BIOMARKER DETECTION Complete
2005 R33 RFA-CA-05-002 BAKER, JAMES R UNIVERSITY OF MICHIGAN AT ANN ARBOR PHOTONIC CRYSTAL FIBER PROBE FLUORESCENCE BIOSENSING Complete
2008 R21 RFA-CA-07-037 WEIER, HEINZ-ULRICH GUENTER UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB ACCELERATING CANCER RESEARCH WITH SINGLE CELL ARRAYS Complete
2011 R21 RFA-CA-10-005 LAWRENCE, DAVID A WADSWORTH CENTER HOLISTIC DIAGNOSTICS OF HOST DURING DEVELOPMENT OF CANCER Complete
2015 R33 RFA-CA-14-004 MANALIS, SCOTT R MASSACHUSETTS INSTITUTE OF TECHNOLOGY SINGLE CELL GROWTH ASSAY FOR RESIDUAL CELLS IN ACUTE LYMPHOBLASTIC LEUKEMIA Complete
2018 R33 RFA-CA-17-013 BORGES, CHAD R ARIZONA STATE UNIVERSITY-TEMPE CAMPUS Validation and Advanced Development of Albumin Oxidizability as a Marker of Plasma/Serum Integrity Complete
1999 R43 PAR-98-066 HAGEN, FREDERICK S ICOGENEX CORPORATION AFFINITY AND TRANSCRIPTASE TECHNOLOGIES Complete
2001 R44 PAR-99-101 BITTER, GRANT A. BITTECH, INC. DNA MISMATCH REPAIR FUNCTIONAL GENETIC TESTS Complete
2004 R44 PAR-01-105 ZEBALA, JOHN A SYNTRIX BIOSYSTEMS, INC. ARTIFICIAL ANTIBODY MIMETICS Complete
2007 R43 RFA-CA-07-008 MEDGHALCHI, SUSAN FASGEN, INC. FATTY ACID SYNTHASE PHOSPHORYLATION AS A CANCER BIOMARKER Complete
2010 R33 RFA-CA-09-007 ROBINSON, JOSEPH PAUL PURDUE UNIVERSITY SPECIFIC DETECTION OF CERVICAL CANCERS USING CYTOMETRY-BASED MOLECULAR DIAGNOSTIC Complete
2014 R43 PAR-13-327 JOHNSON, DAVID SCOTT GIGAGEN, INC. B CELL REPERTOIRE MOLECULAR PLATFORM FOR ANTIBODY DRUG DISCOVERY Complete
2017 R33 RFA-CA-16-002 IBRAHIM, YEHIA BATTELLE PACIFIC NORTHWEST LABORATORIES High Resolution High Throughput Proteomics Platform for Cancer Research Complete
1999 R21 PAR-98-067 WIGLER, MICHAEL H COLD SPRING HARBOR LABORATORY REPRESENTATIONAL APPROACHES TO GENOMIC ANALYSIS Complete
2001 R33 PAR-98-067 WANG, YUE CATHOLIC UNIVERSITY OF AMERICA INTELLIGENT MAPPING OF GENE EXPRESSION PROFILES Complete
2003 R43 PAR-01-105 KRIZMAN, DAVID BURKE EXPRESSION PATHOLOGY, INC PROTEIN ARRAYS FOR MOLECULAR ANALYSIS OF CANCER TISSUE Complete
2007 R21 RFA-CA-07-002 KERR, WILLIAM GARROW H. LEE MOFFITT CANCER CTR & RES INST DEFINING THE MULTIPLE MYELOMA KINOME Complete
2009 R44 RFA-CA-07-010 LEVENSON, RICHARD M. CAMBRIDGE RESEARCH AND INSTRUMENTATION CELLULARLY RESOLVED MOLECULAR PATHWAY ASSESSMENT IN BIOPSIES VIA SPECTRAL IMAGING Complete
2013 R33 RFA-CA-13-002 KUHN, PETER SCRIPPS RESEARCH INSTITUTE CLINICAL VALIDATION OF THE HD-CTC FLUID BIOPSY IN EARLY DETECTION OF LUNG CANCER. Complete
2013 R33 RFA-CA-13-002 BROWN, BRIAN DAVID ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI SENSOR-SEQ: A GENOME-WIDE BIOLOGICAL MEASURE OF MICRORNA ACTIVITY. Complete
2017 R21 RFA-CA-16-001 MALMSTADT, NOAH UNIVERSITY OF SOUTHERN CALIFORNIA A Target-Directed Reagent Pipeline via Microfluidic mRNA Display Complete
2000 R43 PAR-99-101 WILLETT, CATHERINE E PHYLONIX PHARMACEUTICALS, INC. PHARMACOGENOMICS OF CARCINOGENESIS IN WHOLE ANIMALS Complete
2002 R43 PAR-01-105 YANG, CHIHAE LEADSCOPE, INC. A NOVEL CHEMICAL GENOMICS METHODOLOGY Complete
2006 R21 RFA-CA-06-004 HSI, ERIC CLEVELAND CLINIC LERNER COL/MED-CWRU CHARACTERIZATION OF METHODS FOR PRESERVATION OF PHOSPHOPROTEINS IN FIXED TISSUES Complete
2009 R21 RFA-CA-08-006 MC GOWN, LINDA B. RENSSELAER POLYTECHNIC INSTITUTE HYBRIDIZATION OF PROMOTER DNA TARGETS IN CHROMATIN TO DISCOVER REGULATORY PROTEIN Complete
2013 R21 RFA-CA-12-002 CASTRO, CARLOS E. OHIO STATE UNIVERSITY NANOSCALE TOOLS FOR FUNCTIONAL STUDIES OF CANCER-RELEVANT CHROMATIN MODIFICATIONS Complete
2016 R21 RFA-CA-15-002 SADEGHI , SAMAN UNIVERSITY OF CALIFORNIA LOS ANGELES ELECTROCHEMICAL SYNTHESIS OF RADIOPHARMACEUTICALS Complete
2019 R33 RFA-CA-18-003 SOPER, STEVEN ALLAN UNIVERSITY OF KANSAS LAWRENCE Increased Sensitivity of Minimal Residual Disease Monitoring using Peripheral Blood in Pediatric Patients with Acute Lymphoblastic Leukemia Complete
2000 R21 PAR-99-100 CHEE, MARK S. ILLUMINA, INC. PROTEIN PROFILING ARRAYS Complete

Pages